Jpmorgan Chase & CO Apollo Endosurgery, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$9.83 - $9.96 $2.59 Million - $2.63 Million	263,800 Added 24.55%	1,338,150 $13.3 Million
Q4 2022 Feb 13, 2023	BUY	$5.91 - $10.14 $6.35 Million - $10.9 Million	1,074,350 New	1,074,350 $10.7 Million
Q2 2022 Aug 11, 2022	SELL	$3.65 - $6.04 $117,256 - $194,035	-32,125 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$5.01 - $8.77 $112,183 - $196,377	22,392 Added 230.06%	32,125 $194,000
Q4 2021 Feb 10, 2022	BUY	$7.64 - $10.11 $74,360 - $98,400	9,733 New	9,733 $82,000

527K

Ticker APEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,686,500
Description
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible en...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.